Short communicationPublished 2020
A novel anti-CD20 monoclonal antibody shows favorable pharmacodynamic effects and acceptable safety profile in patients with multiple sclerosis
Subjects
Infectious DiseasesFollow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Infectious Diseases and Treatment Open Access
- SubjectInfectious Diseases
- BylineArticles whose byline prints “Maria Morozova”
